PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

SwiftPharma and the Population Council pursue agreement to manufacture Griffithsin needed for the development of a fast-dissolving insert for protection against HIV

2023-09-08
(Press-News.org) September 8, 2023 – SwiftPharma, a Belgium-based manufacturer, and the Population Council, a global nonprofit research organization, have signed a Manufacturing Master Service Agreement for the plant-based manufacture of Griffithsin to further the Council’s development of a Griffithsin fast-dissolving vaginal insert for protection against HIV.  

 

The Population Council has been developing a non-antiretroviral HIV-prevention method containing Griffithsin (GRFT) in a fast-dissolving insert (FDI). This Griffithsin FDI is an on-demand, user-controlled, portable prevention technology in early development that is designed to be manufacturable in low- and middle-income countries.  

 

A user would insert the FDI prior to sex, at which point the FDI would begin to quickly dissolve and blend with the vaginal fluids to coat the inside of the vagina with Griffithsin to provide protection against HIV infection for up to 12 hours.  Griffithsin is a non-antiretroviral HIV entry inhibitor that binds to the HIV envelope glycoproteins and blocks virus entry into target cells. In addition to HIV prevention, preclinical studies have also shown effective prevention against HSV-2 and HPV, and early clinical evaluations have demonstrated an excellent safety profile when delivered as a gel, a precursor product to the FDI. 

 

“This agreement will allow us to efficiently manufacture Griffithsin at the high level of quality needed for the clinical development of this innovative HIV prevention product,” said Dr. Lisa Haddad, Principal Investigator of the project and Medical Director at the Population Council Center for Biomedical Research. “On-demand methods of HIV and STI protection are limited to condoms, for which many people struggle with consistent use. To expand the HIV prevention landscape, more easy-to-use self-administered products are urgently needed.” 

 

“Our HyperXpressTM manufacturing process signifies a pivotal leap in sustainable biomanufacturing. The utilization of Nicotiana benthamiana plants offers a remarkably efficient and scalable solution for low-cost biomanufacturing. This development holds immense promise in the fight against the HIV epidemic, especially for regions with limited resources, and underscores our unwavering dedication to innovation, sustainability, accessibility, and global health improvement,” said Jeroen Hofenk, SwiftPharma’s Founder and Chief Science Officer.  

 

This work is funded by the German Federal Ministry of Education and Research through the KfW Development Bank and MATRIX, a United States Agency for International Development (USAID) Project to Advance the Research and Development of Innovative HIV Prevention Products for Women. Building on favorable outcomes in in vivo models, the current funding will support research to advance the FDI through preclinical studies for its primary indication for HIV prevention, development of a final formulation, and evaluation in Phase 1 trials. 

 

Disclaimer 

MATRIX is made possible by the generous support of the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID). The contents in this press release are those of the Population Council and SwiftPharma and do not necessarily reflect the view of the U.S. President's Emergency Plan for AIDS Relief, the U.S. Agency for International Development or the U.S. Government. 

 

About SwiftPharma 

SwiftPharma is a Belgium-based privately held biotechnology company dedicated to developing next generation, animal-free, and affordable recombinant proteins by transforming plants into mini bioreactors.  The company is on a mission to bring a paradigm shift to multiple industries by serving as a bridge between high unmet industry needs and the significant advances being made in sustainable biomanufacturing. For more information, visit www.swiftpharma.eu 

 

About the Population Council 

The Population Council is a leading research organization dedicated to building an equitable and sustainable world that enhances the health and well-being of current and future generations. We generate ideas, produce evidence, and design solutions to improve the lives of underserved populations around the world. Learn more at www.popcouncil.org. 

END


ELSE PRESS RELEASES FROM THIS DATE:

What defines a safety-net hospital?

2023-09-08
Safety-net hospitals have a common mission to provide care for Medicaid beneficiaries and those who are uninsured, but there’s no universal definition for these hospitals—complicating efforts to allocate funding. In a new analysis published in JAMA Network Open and led by researchers at the NYU School of Global Public Health, the research team looked at five established definitions for safety-net hospitals and found that different criteria captured varying hospitals and characteristics. As a result, when the Centers for Medicaid and Medicare Services (CMS) use one definition ...

Heatwaves hitting Antarctica too

Heatwaves hitting Antarctica too
2023-09-08
The world saw another year full of extreme weather events resulting from climate change in 2022, from intense storms to soaring temperatures and rising sea levels. Antarctica was no exception, according to new research published this week.    In the 33rd annual State of the Climate report, an international assessment of the global climate published Sept. 6 in the Bulletin of the American Meteorological Society, CU Boulder researchers report that the planet’s coldest and driest continent experienced both an unprecedented heatwave and extreme precipitation last year.  “My hope is that the public starts to see both the fragility and complexity of these ...

These worms have rhythm

These worms have rhythm
2023-09-08
There’s a rhythm to developing life. Growing from a tiny cell cluster into an adult organism takes precise timing and control. The right genes must turn on at the right time, for the right duration, and in the correct order. Losing the rhythm can lead to diseases like cancer. So, what keeps every gene on beat? Cold Spring Harbor Laboratory (CSHL) Professor Christopher Hammell has found that in the worm C. elegans, this genetic orchestra has no single conductor. Instead, a quartet of molecules works in concert to time each developmental stage. Hammell says this process shares some similarities with the circadian clocks that control human ...

Sleep-wake therapy gives new hope for teens with depression

2023-09-08
Sleep-Wake Therapy Gives New Hope for Teens with Depression  Promoting healthy sleep in teen night owls brings adolescents’ biology and school demands in alignment.  School systems aren’t built for kids who fall asleep and wake up late, the so-called “night owls,” which may help explain why this group of teens is more prone to depression.  Now, researchers at UC San Francisco have found a way to help these kids adjust to their natural sleep-cycle rhythms while still fulfilling their school responsibilities. The findings are a welcome sign for adolescents with ...

Study explores an underappreciated way warmer temperatures will impact ecosystems: Decomposition

Study explores an underappreciated way warmer temperatures will impact ecosystems: Decomposition
2023-09-08
Our world is changing, and warming temperatures will alter our natural ecosystems. Some of these changes will be straightforward, like animal ranges creeping northward as they strive to maintain their ideal temperatures. But other changes will be more complicated, as warming sets off complex chain reactions that reverberate through these systems. An important process in ecosystems is the decomposition of plant litter, in which dead plant material is broken down by animals, fungi, and microbes, making its nutrients accessible to the next generation of plants. How quickly this breakdown happens — the decomposition ...

UMBC team of data scientists named a tools competition winner

2023-09-08
Baltimore – A team of four data scientists from the University of Maryland, Baltimore County, was named today as one of 32 winners of the Tools Competition, one of the largest education technology (edtech) competitions in the world that awarded more than $4 million to winners this year.  The team was a winner in the DARPA AI Tools for Adult Learning opportunity, which sought artificial intelligence-powered tools to help adults learn complex topics necessary for the current and future national security workforce (e.g., AI engineering ...

Synchrotron studies change the composition of the Earth’s core

2023-09-08
In work published in Science Advances, a team of researchers have determined a new pressure scale, which is critical for understanding the Earth’s composition. Using x-rays from a uniquely powerful spectrometer at RIKEN’s SPring-8 Center they avoided some of the large approximations of previous work, discovering that the previous scale overestimated pressure by more than 20% at 230 gigapascals (2.3 million atmospheres) - a pressure reached in Earth’s core. This is similar to someone running a marathon that they thought was 42 kilometers, but finding they had only really run 34 kilometers. While 20% might seem like a modest correction, it has big implications.  An accurate ...

Applications now open for early-career Latin American science journalists to receive EurekAlert! Fellowships and attend the AAAS Annual Meeting

Applications now open for early-career Latin American science journalists to receive EurekAlert! Fellowships and attend the AAAS Annual Meeting
2023-09-08
The EurekAlert! Fellowships for International Science Reporters are back and now accepting applications from early-career Latin American science journalists. Two fellows will be selected to receive travel funding from EurekAlert! to attend the 2024 AAAS Annual Meeting, taking place February 15-17, 2024 in Denver, Colorado. Learn more about who is eligible and how to apply on our website. The application deadline is October 5, 2023 at 11:59 p.m. US Eastern Time. The American Association for the Advancement of Science (AAAS) ...

British sex lives revealed in new study

2023-09-08
A new study published today shows the number of sexual partners we have changes as we age – and there are some surprising results.  Researchers from the University of East Anglia (UEA), in collaboration with King’s College London and University College London, surveyed more than 5,000 people aged 18 years and older during the 2022 mpox (previously known as “monkeypox”) outbreak.   The team wanted to better understand how sexual behaviours change with age, so that mathematical models of sexually transmitted infections can be made more accurate. Key findings included in the paper, published today ...

How trees influence cloud formation

How trees influence cloud formation
2023-09-08
As part of the international CLOUD project at the nuclear research centre CERN, researchers at PSI have identified so-called sesquiterpenes – gaseous hydrocarbons that are released by plants – as being a major factor in cloud formation. This finding could reduce uncertainties in climate models and help make more accurate predictions. The study has now been published in the journal Science Advances. According to the latest projections of the Intergovernmental Panel on Climate Change (IPCC), the global climate will be 1.5 to 4.4 degrees Celsius warmer than pre-industrial levels by 2100. This figure is based on various scenarios describing how anthropogenic ...

LAST 30 PRESS RELEASES:

Dr. Gianluca Ianiro wins a prestigious grant from the European Research Council (ERC)

‘Rogue’ DNA rings reveal earliest clues to deadly brain cancer’s growth

Clinical study deepens understanding of mesothelioma and opens the door to potential treatment options

New study and major data updates expand the Kids First data ecosystem

Seaweed snare: Sargassum stops sea turtle hatchlings in their tracks

Scientists uncover key to decoupling economic growth from pollution in developing countries

Frailty fuels gut imbalance and post-surgery gastrointestinal risks

BMS-986504 demonstrates durable responses in MTAP-deleted NSCLC, including EGFR and ALK-positive tumors

Phase III trial finds hypofractionated radiotherapy with chemotherapy offers comparable survival and lower toxicity to conventional schedule in LS-SCLC

Lung cancer screening benefits adults up to age 80 if surgical candidates, UK study finds

Video assisted thoracoscopy surgery reduces mortality by 21 percent compared to lobectomy

NADIM ADJUVANT trial suggests benefit of adjuvant chemo-immunotherapy in resected stage IB–IIIA NSCLC

EA5181 phase 3 trial finds no OS benefit for concurrent and consolidative durvalumab vs consolidation alone in unresectable stage 3 NSCLC

Training to improve memory

Are patients undergoing surgery for early-stage cancer at risk of persistent opioid use?

Black youth, especially Black girls, use mental health services less than their White peers

Canada must protect youth from sports betting advertising

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

[Press-News.org] SwiftPharma and the Population Council pursue agreement to manufacture Griffithsin needed for the development of a fast-dissolving insert for protection against HIV